from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2585c/-

LFCtreatmentdescriptionclass of inhibitor

2.405

Amikacinug/mL Amikacintranslation

2.148

Cap5-10ug/mL Capreomycintranslation

2.053

Rox10-50 ug/mL Roxithromycintranslation

0.476

SM2-5 ug/mL Streptomycintranslation

1.421

Tet5-10 ug/mL Tetracyclinetranslation

1.207

Rif0.2-5ug/mL Rifampicintranscription

0.057

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.626

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.634

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.200

CPZ10-50 ug/mL Chlorpromazinerespiration

0.109

Clofazimine10-13 ug/mL Clofaziminerespiration

0.117

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.375

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.821

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.639

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.023

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.141

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.479

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.226

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.760

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.759

KCN5-20 ug/mL Potassium cyaniderespiration

-0.640

NaN30.2-2 mM Sodium aziderespiration

0.494

Nigericin50 uM Nigericinrespiration

-0.931

TRC10-150 ug/mL Triclosanrespiration

-0.317

TRZ10-25 ug/mL Thioridazinerespiration

-0.496

Valinomycin0.5-10 uM Valinomycinrespiration

0.293

ZnSO42 mM ZnSO4respiration

-0.367

menadione6-10 ug/mL Menadionerespiration

-0.005

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.377

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.113

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.390

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.522

NRP_1Non-replicating persistence stage 1dosRassociated

0.969

Amp0.2mg/mL AmpicillincellWall

0.192

Cephalexin20-100 ug/mL CephalexincellWall

0.170

Cerulenin0.32-5 ug/mL CerulenincellWall

1.228

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.813

EMB10-20 ug/mL EthambutolcellWall

0.481

Eta12-40 ug/mL EthionamidecellWall

0.418

INH0.2-0.4 ug/mL IsoniazidcellWall

0.230

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.565

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.378

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.600

BZA0.12 mg/mL BenzamidearomaticAmides

-0.246

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.450

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.382

H2O24 mM hydrogen peroxideDNAdamaging

-0.240

Levo10 ug/mL LevofloxacinDNAdamaging

0.392

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.205

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.057

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.765

UVUV-irradiationDNAdamaging

-0.607

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.107

Antimycin12.5-50 ug/mL Antimycin A?

0.453

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.164

PA_110-50 ug/mL Antitubercular compound PA-1?

0.109

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.647

PA8240.2-2 ug/mL PA-824?

-1.334

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.784

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.148

Verapamil50 uM Verapamil?

-0.205

mercaptoethanol2 mM 2-Mercaptoethanol?

0.162

methoxatin10-20 ug/mL Methoxatin?